Advisors Asset Management Inc. Buys 6,312 Shares of Sabra Healthcare REIT, Inc. $SBRA

Advisors Asset Management Inc. boosted its stake in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 3.6% in the second quarter, HoldingsChannel reports. The firm owned 183,189 shares of the real estate investment trust’s stock after acquiring an additional 6,312 shares during the period. Advisors Asset Management Inc.’s holdings in Sabra Healthcare REIT were worth $3,378,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in SBRA. Geode Capital Management LLC boosted its stake in shares of Sabra Healthcare REIT by 0.8% in the 2nd quarter. Geode Capital Management LLC now owns 6,613,185 shares of the real estate investment trust’s stock worth $121,960,000 after buying an additional 55,200 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in Sabra Healthcare REIT by 1.5% in the second quarter. Bank of New York Mellon Corp now owns 4,175,058 shares of the real estate investment trust’s stock valued at $76,988,000 after acquiring an additional 60,843 shares during the period. Nuveen LLC purchased a new position in Sabra Healthcare REIT in the first quarter worth about $61,791,000. Bank of Montreal Can grew its stake in shares of Sabra Healthcare REIT by 244.1% during the 2nd quarter. Bank of Montreal Can now owns 2,575,969 shares of the real estate investment trust’s stock valued at $47,501,000 after purchasing an additional 1,827,361 shares during the period. Finally, Duff & Phelps Investment Management Co. increased its position in shares of Sabra Healthcare REIT by 0.6% during the 2nd quarter. Duff & Phelps Investment Management Co. now owns 2,549,438 shares of the real estate investment trust’s stock valued at $47,012,000 after purchasing an additional 16,069 shares during the last quarter. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Price Performance

Shares of Sabra Healthcare REIT stock opened at $19.48 on Friday. The firm has a market cap of $4.86 billion, a PE ratio of 25.63, a PEG ratio of 1.10 and a beta of 0.84. The stock has a 50 day moving average of $18.37 and a 200 day moving average of $18.39. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. Sabra Healthcare REIT, Inc. has a 12 month low of $15.60 and a 12 month high of $19.97.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, November 5th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.37 by $0.01. The business had revenue of $190.04 million for the quarter, compared to analysts’ expectations of $193.44 million. Sabra Healthcare REIT had a return on equity of 6.69% and a net margin of 24.87%.The company’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same period in the prior year, the firm earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.455-1.465 EPS. On average, research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Shareholders of record on Monday, November 17th were given a dividend of $0.30 per share. The ex-dividend date was Monday, November 17th. This represents a $1.20 annualized dividend and a yield of 6.2%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 166.67%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on SBRA. Wall Street Zen cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Cantor Fitzgerald began coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target on the stock. JMP Securities boosted their price objective on shares of Sabra Healthcare REIT from $20.00 to $22.00 and gave the company a “market outperform” rating in a research report on Wednesday, August 6th. Truist Financial raised their target price on Sabra Healthcare REIT from $18.00 to $20.00 and gave the stock a “hold” rating in a report on Tuesday, September 2nd. Finally, BMO Capital Markets lifted their target price on Sabra Healthcare REIT from $19.00 to $22.00 and gave the company a “market perform” rating in a research report on Monday, August 25th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $20.78.

Sabra Healthcare REIT Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.